GeneSeek Selects the British Midlands as Base for New UK/European ...( US Research and Product Developme...)

US Research and Product Development Company to Establish Presence in

UK/European Market from the Midlands

CHICAGO, Dec. 14 /PRNewswire/ -- Today the British Midlands Development Corporation announced that Nebraska based GeneSeek has chosen the British Midlands as the location for their new European operation.

GeneSeek will be setting up their new base of operations in BioCity Nottingham, the UK's largest bioscience and healthcare innovation center. BioCity provides state-of-the-art laboratories, equipment, and office space for bioscience start-up companies and has the perfect infrastructure for GeneSeek to establish its presence in the European market.

"European expansion is an important component of GeneSeek's growth strategy which also includes new laboratory and offices in India to address the Asian market," said Abe Oommen, President and CEO of GeneSeek, "By selecting BioCity Nottingham as the location for our European operations, we'll be able to leverage the region's skill base, well-established science industry, and access all of our key markets."

"We've worked closely with the investment team at the British Midlands as well as BioCity to make this project happen," said Oommen, "GeneSeek is ready to take on the opportunities in these new markets and launch the next phase of the company's growth."

"GeneSeek and its research and development operations are well suited for the British Midlands," said Vern Sebby, President and CEO of British Midlands Development Corporation, "We have 17-world class universities with UK leading research in genomics and clinical diagnostics, as well as one the strongest science industry clusters in Europe."

"We're thrilled that GeneSeek chose the Midlands," continued Sebby, "We look forward to continuing our support and sharing regional expertise with them as the company's European operations grow."

About GeneSeek

GeneSeek provides comprehensive res
'/>"/>